News
7d
GlobalData on MSNFDA approves GSK’s prefilled syringe presentation of ShingrixAdministering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...
Immunizations. Getting the shingles vaccine (Shingrix) is recommended for women and men at age 50. Dr. Gidwani also advises ...
Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.
This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe ...
The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...
London: GSK plc has received approval from the US Food and Drug Administration (FDA) for a prefilled syringe presentation of ...
4d
ScienceAlert on MSNHuge Study Reveals 2 Vaccines That Appear to Reduce Dementia RiskThe retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results